Treatment of anorexia and malnutrition in peritoneal dialysis patients with megestrol acetate.

Author: AguileraAbelardo, BajoM Auxiliadora, CosteroOlga, GilFernando, HeviaCovadonga, RosSilvia, SelgasRafael, del PesoGloria

Paper Details 
Original Abstract of the Article :
Anorexia and malnutrition are common complications and powerful predictors of morbidity and mortality in peritoneal dialysis (PD) patients. Megestrol acetate (MA) is a progestogen that has been demonstrated to increase appetite and weight in patients with cancer or acquired immunodeficiency syndrome...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/15384828

データ提供:米国国立医学図書館(NLM)

Megestrol Acetate: A Potential Treatment for Anorexia and Malnutrition in Peritoneal Dialysis Patients

Peritoneal dialysis (PD) is a common treatment for kidney failure, but it can lead to complications like anorexia and malnutrition, which significantly impact patient health and survival. Megestrol acetate (MA) is a drug that has shown promise in stimulating appetite and promoting weight gain in patients with cancer and HIV/AIDS. This study investigates the potential benefits of MA in treating anorexia and malnutrition in PD patients.

Megestrol Acetate: A Potential Solution for Anorexia and Malnutrition in PD Patients

This study found that MA significantly improved appetite and weight in the majority of PD patients. While serum albumin levels showed a nonsignificant increase, the study suggests that MA could be a valuable tool for managing malnutrition in PD patients. The study also highlights the absence of significant side effects, further supporting the potential benefits of MA therapy. This study offers hope for PD patients struggling with anorexia and malnutrition, suggesting that MA could play a crucial role in improving their overall health and well-being.

Addressing Malnutrition in Peritoneal Dialysis Patients: A Multifaceted Approach

The study emphasizes the importance of addressing the complex issue of malnutrition in PD patients. The findings suggest that MA could be an effective treatment option, but it's crucial to recognize that malnutrition is a multifaceted problem requiring a comprehensive approach. This study encourages patients and physicians to work together to develop individualized treatment plans that address the underlying causes of malnutrition and optimize patient outcomes.

Dr. Camel's Conclusion

This study explores the potential of MA to combat malnutrition in PD patients, highlighting its ability to stimulate appetite and promote weight gain. Like a camel adapting to the harsh desert environment, PD patients require tailored strategies to manage their health challenges. This study underscores the importance of a multidisciplinary approach to address malnutrition, ensuring the best possible care for individuals with kidney failure.

Date :
  1. Date Completed 2004-11-06
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

15384828

DOI: Digital Object Identifier

15384828

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.